The clinical approach to menopause in the UK has reached a landmark stage in 2025 with the formal inclusion of menopause-specific questions within the standard NHS Health Check. This systemic change reflects a growing understanding of the physiological impact of declining oestrogen levels on bone density, cardiovascular health, and cognitive function. For the estimated 13 million perimenopausal and menopausal women in the UK, this ensures that symptoms such as vasomotor instability and genitourinary syndrome of menopause are screened for during routine primary care visits. According to the UK Women's Healthcare Sector, the use of body-identical Hormone Replacement Therapy (HRT) has become the gold standard for symptom relief, supported by updated clinical guidelines that clarify the safety profile and long-term benefits of treatment for most women. This proactive screening model aims to prevent the onset of postmenopausal osteoporosis and other chronic conditions through early intervention and lifestyle education.

Frequently Asked Questions

Q. At what age can women access the new menopause health check? A. It is typically integrated into the standard NHS Health Check offered to adults aged 40 to 74, specifically targeting the perimenopausal transition phase.

Q. What is "body-identical" HRT? A. These are hormonal treatments that have the same molecular structure as the hormones naturally produced by the human body, often derived from plant sources like yams.